← FDA DRUG APPROVALS

FDA ANDA · ANDA091554

VANCOMYCIN HYDROCHLORIDE

Sponsor: MYLAN LABS LTD

APPLICATION
ANDA091554
TYPE
ANDA
ORIGINAL APPROVAL
2011-09-19
LATEST ACTION
2021-04-07
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

VANCOMYCIN HYDROCHLORIDEPrescription
VANCOMYCIN HYDROCHLORIDE EQ 10GM BASE/VIAL · INJECTABLE · INJECTION

Approval history

2021-04-07Labeling · Supplement 14 · standardAP
2021-04-07Labeling · Supplement 15 · standardAP
2020-08-19Labeling · Supplement 6 · standardAP
2020-08-19Labeling · Supplement 13 · standardAP
2020-08-19Labeling · Supplement 11 · standardAP
2014-11-07Labeling · Supplement 5 · standardAP
2011-09-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →